Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
US OptionsDetailed Quotes
ALT250502C10500
- 0.15
- 0.000.00%
15min DelayClose May 2 16:00 ET
0.00High0.00Low
0.15Open0.15Pre Close0 Volume1 Open Interest10.50Strike Price0.00Turnover0.00%IV84.58%PremiumMay 2, 2025Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma38.47Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Altimmune Newsroom
Evercore Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $25
Analysts Are Bullish on These Healthcare Stocks: Summit Therapeutics (SMMT), Altimmune (ALT)
JMP Securities Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $25
H.C. Wainwright Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $12
Altimmune Price Target Maintained With a $25.00/Share by Citizens Capital Markets
Altimmune Analyst Ratings
JMP Securities Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $25
Analysts Offer Insights on Healthcare Companies: Altimmune (ALT), Cue Biopharma (CUE) and Atricure (ATRC)
JMP Securities Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $25
H.C. Wainwright Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $12
Altimmune's Pemvidutide: A Promising Best-in-Class Therapy With Broad Potential and Strong Buy Rating
A Quick Look at Today's Ratings for Altimmune(ALT.US), With a Forecast Between $18 to $25
Altimmune Price Target Maintained With a $25.00/Share by Citizens Capital Markets
Altimmune Analyst Ratings
William Blair Maintains Altimmune(ALT.US) With Hold Rating
JMP Securities Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $25
Promising Potential of Altimmune's Pemvidutide Drives Buy Rating Amid Expanding Indications and Strong Market Outlook
William Blair Maintains Altimmune(ALT.US) With Hold Rating
William Blair Maintains Altimmune(ALT.US) With Hold Rating
Altimmune (ALT) Initiated With a Hold at William Blair
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
